Gavin Ernstone, founder of Simply Vegas, has published a free ebook sharing insights from over 30 years in Las Vegas luxury real estate. The ebook covers how to choose a luxury agent, navigate off-market deals, understand new construction trends, and manage tax and residency issues for buyers relocating from California. This resource aims to help high-net-worth buyers and sellers make informed decisions in the competitive Las Vegas market, which has attracted many wealthy buyers due to Nevada's tax advantages. Ernstone's extensive experience includes selling over $1.3 billion in real estate, making this guide valuable for luxury home transactions.
Gavin Ernstone's guide for luxury Las Vegas real estate buyers and sellers is presented here with Pluang's real estate sector data for context. Of 22 priced US real estate stocks on Pluang, 20 rose and 1 fell today. Notable movers include PSA at USD 298.65 with a 1-day change of +1.35%, IIPR at USD 56.55 with 100% sell order activity, and PLD at USD 135.26 with 100% buy order activity, as of Sep 17, 2026 23:42 WIB.
KB Home is set to report its Q3 2026 earnings on September 22, with analysts projecting a 45.3% drop in earnings per share to around $0.89 and a 20.2% decline in revenue to about $1.30 billion compared to last year. The consensus EPS estimate has rec...
An investment of $10,000 in Nebius when it resumed trading in 2024 has grown significantly to approximately $105,000 by 2026. This remarkable increase highlights Nebius's strong market performance over the two-year period. Investors who bought in at ...
W.P. Carey expects to invest over $1.9 billion in 2026, reflecting robust growth in its net lease property portfolio. Despite a slight reduction in its price target by Scotiabank to $76, the stock still shows potential upside from current levels. The...
Micron Technology is investing $10 billion over the next decade to establish Micron Research Labs, a new division focused on future memory architectures and advanced semiconductor manufacturing. The company shows strong financial health with a low de...
Impact Biomedical Inc. will conduct a 1-for-12.62 reverse stock split on September 23, 2026, consolidating shares without changing shareholder value. This move facilitates its planned merger with Zoar Ltd., with a Form F-4 registration filed with the...
